AC is characterized by painful, gradual loss of active and passive shoulder motion, resulting from fibrosis and contracture of the joint capsule. Estimated incidence of AC is 2% to 5% in the general population (
1). Physical examination does not reveal a specific point of tenderness and rotator cuff strength is usually normal. A mechanical restraint to passive motion is the hallmark of AC. AC progresses from capsular inflammation to fibrosis according to the stage. Especially in the pre-adhesive stage, symptoms are nonspecific and misdiagnosis is common (
5). In this regard, although diagnosis of AC remains a clinical entity, imaging findings are useful in excluding other conditions that may cause similar symptoms. Furthermore, with the increasingly broad use of imaging modalities, they can play a greater role than simply excluding other conditions (
6-
11).
Various MRI findings of AC have been reported and include thickening and signal changes in the inferior glenohumeral ligament, subcoracoid fat obliteration around the rotator interval, and contrast enhancement of the joint capsule (
6-
8). Contrast enhancement is not essential for diagnosing AC, but is fairly helpful in MRI (
7,
8). Tamai et al. postulated that contrast enhancement of the joint capsule seems to be associated with increased vascularity in the synovium and subsynovial layer in AC (
19).
Contrary to MRI, US findings of AC are not as prevalent in the literature (
9-
12). This could be related to the limited approach of US for visualizing the shoulder joint capsule, although US has the advantages of lower cost and easy accessibility. Michelin et al. reported inferior glenohumeral thickening in shoulders with AC in a maximally abducted position (
12). They suggested that assessment of axillary recess is more useful, because the rotator interval could be influenced by other conditions, such as biceps pulley lesion or biceps/subscapularis tendinopathy, and it is difficult to obtain a reliable thickness measurement of the coracohumeral ligament. However, in our preliminary trial, a patient with AC, who mostly suffered from pain and limited range of motion, had difficulty in maintaining an abducted shoulder position to evaluate the axillary recess during our CEUS exam. Other studies using US for AC have mainly focused on the rotator interval. Homsi et al. reported that a thickened coracohumeral ligament was a finding suggestive of AC on oblique axial and sagittal planes over a neutrally positioned arm (
10). In the present study, we did not evaluate the coracohumeral ligament thickness, because it was not easily measurable, as noted by Michelin et al. Instead, we could see the obvious enhancement of the coracohumeral ligament together with the superior glenohumeral ligament on CEUS in the rotator interval of the symptomatic shoulders.
Lee et al. described hypoechoic change and increased vascularity in the rotator interval as a finding of AC, with 87% sensitivity and 100% specificity (
9). Walmsley et al. also reported increased vascularity in the rotator interval in their Doppler study, however, this finding was only observed in 29% of patients with early-stage AC (
11). Although Doppler US can reveal increased vascularity in the rotator interval in patients with AC, this method is limited because it can only detect larger vessels with signals above the noise level and with flow velocities above the threshold of the wall filter (
14,
15). We hypothesized that CEUS could overcome this limitation and increase the detectability of vascular flow in an inflamed joint capsule.
Various applications of CEUS have been reported in assessing the vascularity of joints, and most studies agree that CEUS effectively visualizes the synovial vascularity, especially in rheumatoid arthritis (
20-
22). CEUS was more sensitive than Doppler US and helpful in differentiating active and inactive rheumatoid arthritis, so it is clinically useful in early detection and in monitoring therapeutic response. To our knowledge, this is the first study of CEUS applied to the shoulders of patients with AC, and we have concluded that CEUS can directly detect capsular enhancement, possibly due to inflammation.
We analyzed the CEUS-derived TIC curves for vascular flow and perfusion of the joint capsule. The TIC of affected shoulders showed a lognormal fitting curve, which is the usual pattern of tissue perfusion after bolus injection of a contrast agent. However, in asymptomatic shoulders, there was a trend of no remarkable increase between baseline and thereafter intensities. This is likely the result of slow, low-volume blood flow of the normal joint capsule, which can hardly be detected, even when using a contrast agent. Among the parameters of TIC, TTP is related to vascular flow of the analyzed region, while PI and rate-of-rise represent vascular volume and perfusion, respectively (
18,
23). In a study by Platzgummer et al., which evaluated the TIC in patients with hand and wrist synovitis due to rheumatoid arthritis, the TTP ranged from 8.13 to 36.2 (mean: 18.6) and PI from 1.61 to 15.7 (mean: 7.51) (
17). Their results with rheumatoid arthritis appear to be comparable to ours with AC, where TTP ranged from 25.8 to 39.5 (mean: 30.6) and PI from 3.12 to 10.03 (mean: 5.45). In comparing CEUS scores of 1 and 2, cases with score 1 showed slower TTP, smaller PI, and similar rate-of-rise, which represents relatively slower vascular flow, lower vascular volume, and similar perfusion in the ROI.
Our study has several limitations. The major limitation is the small size of the study population that might be biased because we only included the AC patients who underwent MRI. Due to the small sample size, we could not consider the effect of the laterality of the IV route, gender, age, and symptom duration, all of which could possibly influence the enhancing pattern and quantification parameters. In addition, the borderline p-values in our results could be derived from the small sample size. Considering clinically different numeric profiles, a larger sample study may yield better results. A larger population study is required to validate our results.
Another limitation is the absence of reliability testing on the CEUS exam and quantification analysis. Due to the short time window of CEUS, we could not include an observer variability test in our study. In our study, the existence of contrast enhancement was evident in all cases and slight imaging plane inconsistency was not a significant problem. However, our quantification method has limitations, particularly in ROI selection. Since the ROI did not cover the overall enhancing capsule, the parameters derived from our ROI may contain limited information regarding vascular volume or perfusion. Due to the paucity of available quantification data regarding CEUS of the shoulder joint capsule, we could not compare our results with other references.
In conclusion, our preliminary results revealed that CEUS was capable of demonstrating capsular enhancement, possibly from inflammation, of the rotator interval in patients with AC, and the findings of CEUS were comparable to those of MRI.